U

University of the Ryukyus Hospital | Clinical Research Support Center

Research site
(Unclaimed)
Location
207 Uehara Nakagamigun, Nishihara, Okinawa, Japan
Site insights

Top conditions

Pneumonia (1 trial)

Psoriasis (1 trial)

Crohn Disease (1 trial)

Ventilator-Associated Pneumonia (1 trial)

Hematologic Cancer (1 trial)

Top treatments

JNJ-77242113
MK-3475
MK-3475-587
Pembrolizumab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

2 of 4
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

The purpose of the study is to see how effective JNJ-77242113 is in participants with moderate to severe plaque psoriasis compared to placebo and deu...

Enrolling
Plaque Psoriasis
Drug: Deucravacitinib Matching Placebo
Drug: JNJ-77242113

The purpose of this study is to evaluate the long-term safety and efficacy of pembrolizumab (MK-3475) in participants from previous Merck pembrolizum...

Enrolling
Solid Tumors
Hematologic Malignancies
Drug: Pembrolizumab
Drug: Lenvatinib

Trial sponsors

AbbVie logo

AbbVie (1 trial)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems